Lucid Diagnostics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,172 | $976 | $1,000 | $1,040 |
Gross Profit | -512 | -867 | -1,156 | -1,045 |
EBITDA | -12,155 | -10,770 | -10,099 | -10,190 |
EBIT | -12,370 | -10,999 | -10,600 | -10,819 |
Net Income | -12,371 | -11,005 | -10,612 | -10,830 |
Net Change In Cash | 1,172 | 976 | 1,000 | 1,040 |
Free Cash Flow | -10,525 | -11,482 | -12,649 | -10,154 |
Cash | 14,489 | 24,920 | 24,769 | 18,896 |
Basic Shares | 50,374 | 48,212 | 45,014 | 42,329 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,428 | $377 | $500 | $0 |
Gross Profit | -6,050 | -3,237 | -85 | 0 |
EBITDA | -49,751 | -54,235 | -27,415 | -8,279 |
EBIT | -52,250 | -56,171 | -27,419 | -8,279 |
Net Income | -52,666 | -56,171 | -28,737 | -8,279 |
Net Change In Cash | 2,428 | 377 | 500 | 0 |
Cost of Revenue | -31,182 | |||
Free Cash Flow | -33,038 | -30,593 | -18,530 | -5,628 |
Cash | 18,896 | 22,474 | 53,656 | 111 |
Basic Shares | 41,756 | 36,172 | 34,917 | 36,992 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.20 |
2024-06-30 | -$0.23 |
2024-03-31 | -$0.40 |
2023-12-31 | -$0.25 |
